Meeting Introduction
Raymond Schulz, MSc
Director SRS Programs, Medical Affairs
Varian Medical Systems, Palo Alto, CA
Watch the video
Clinical Benefits of HyperSight Imaging Solution
Michael Prusator, PhD
Washington University, St. Louis, MO
Watch the video
Commissioning of IDENTIFY SGRS 2.3: What we have learned
Richard Popple, PhD
University of Alabama at Birmingham, Birmingham, AL
Watch the video
High Volume HyperArc at a Community Cancer Center: Physics POV
Zachary Christ, MS, DABR
Forrest General CC, Hattiesburg, MS
Watch the video
High Volume HyperArc at a Regional Cancer Center: Radiation Oncologist POV
Catherine Mercado, MD
Orlando Health CC, Orlando, FL
Watch the video
Functional SRS on Edge: Current Practice & Future Potential
Evan Thomas, MD, PhD
Ohio State University Medical System, Columbus, OH
Watch the video
DEBATE Proposition: SRS for <= 15 Metastases (vs SRS > 15 Metastases)
For the Proposition: SRS for 15 Metastases is the absolute max: Timothy J. Harris, MD, PhD: Virginia Commonwealth University, Richmond, VA
Against the Proposition: SRS for > 15 Metastases benefits many patients: Raju Raval, MD, D. Phil: Ohio State University, Columbus, OH
Watch the video
Taking the EDGE off Cancer: Q&A
Panel and Audience
Watch the video
FOR EDUCATIONAL AND SCIENTIFIC EXCHANGE ONLY – NOT FOR SALES OR PROMOTIONAL USE.